These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29193772)

  • 1. Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma.
    Rigaud C; Abbou S; Minard-Colin V; Geoerger B; Scoazec JY; Vassal G; Jaff N; Heuberger L; Valteau-Couanet D; Brugieres L
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29193772
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Relapsed and Refractory ALK-Positive Anaplastic Large Cell Lymphoma With ALK-Specific Tyrosine Kinase Inhibitor in Children: A Case Series.
    Shen D; Song H; Zhang J; Liao C; Wang Y; Fang M; Tang Y
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e1-e4. PubMed ID: 33661174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK
    Jiang X; Zhou D
    Blood; 2018 Apr; 131(15):1764. PubMed ID: 29650733
    [No Abstract]   [Full Text] [Related]  

  • 4. Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL).
    Eisfeld H; Kircher S; Rosenwald A; Anagnostopoulos I; Werner M; Gaßler N; Wolf G; Lehmkuhl L; Teichgräber U; Gühne F; Darr A; Freesmeyer M; Weschenfelder W; Hofmann G; Dalkilic R; Kalff R; Hochhaus A; Schrenk KG
    Ann Hematol; 2021 Apr; 100(4):1107-1109. PubMed ID: 32895754
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
    Bossi E; Aroldi A; Brioschi FA; Steidl C; Baretta S; Renso R; Verga L; Fontana D; Sharma GG; Mologni L; Mussolin L; Piazza R; Gambacorti-Passerini C
    Am J Hematol; 2020 Dec; 95(12):E319-E321. PubMed ID: 32808682
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of anaplastic lymphoma kinase-negative anaplastic large cell lymphoma on pleural fluid cytology.
    Greenland NY; Lu CM; Cook S; Peng Y
    Diagn Cytopathol; 2021 Dec; 49(12):E458-E461. PubMed ID: 34406711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
    Anderson J; Putnam E; Liu W; Menon MP
    Int J Lab Hematol; 2022 Feb; 44(1):67-68. PubMed ID: 34019742
    [No Abstract]   [Full Text] [Related]  

  • 8. ALK-positive anaplastic large cell lymphoma, Hodgkin-like pattern with unexplained fever.
    Tabata R; Matsue K
    Blood; 2024 Sep; 144(13):1460. PubMed ID: 39325483
    [No Abstract]   [Full Text] [Related]  

  • 9. A Phase I/II Study of Crizotinib for Recurrent or Refractory Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma and a Phase I Study of Crizotinib for Recurrent or Refractory Neuroblastoma : Study Protocol for a Multicenter Single-arm Open-label Trial.
    Sekimizu M; Osumi T; Fukano R; Koga Y; Kada A; Saito AM; Mori T
    Acta Med Okayama; 2018 Aug; 72(4):431-436. PubMed ID: 30140094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should treatment of ALK-positive anaplastic large cell lymphoma be stratified according to minimal residual disease?
    Rigaud C; Abbas R; Grand D; Minard-Colin V; Aladjidi N; Buchbinder N; Garnier N; Plat G; Couec ML; Duplan M; Lambilliotte A; Schmitt C; Leblanc T; Lamant L; Brugières L
    Pediatr Blood Cancer; 2021 Jun; 68(6):e28982. PubMed ID: 33687135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib.
    Graetz D; Crews KR; Azzato EM; Singh RK; Raimondi S; Mason J; Valentine M; Mullighan CG; Holland A; Inaba H; Leventaki V
    Haematologica; 2019 May; 104(5):e218-e221. PubMed ID: 30819904
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase 1/2 Study of the Safety and Tolerability of Nivolumab Plus Crizotinib for the First-Line Treatment of Anaplastic Lymphoma Kinase Translocation - Positive Advanced Non-Small Cell Lung Cancer (CheckMate 370).
    Spigel DR; Reynolds C; Waterhouse D; Garon EB; Chandler J; Babu S; Thurmes P; Spira A; Jotte R; Zhu J; Lin WH; Blumenschein G
    J Thorac Oncol; 2018 May; 13(5):682-688. PubMed ID: 29518553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK-negative anaplastic large cell lymphoma, null type with aberrant expression of PAX5 and CD138: A diagnostic pitfall.
    Salyana MA; Khan S; Zhang X
    Diagn Cytopathol; 2021 Oct; 49(10):E395-E399. PubMed ID: 34190415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
    Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38 is not expressed in pediatric ALK-positive anaplastic large cell lymphoma.
    Au-Yeung RKH; Burkhardt B; Woessmann W; Klapper W
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27541. PubMed ID: 30408331
    [No Abstract]   [Full Text] [Related]  

  • 16. Composite ALK-negative anaplastic large cell lymphoma and follicular lymphoma involving jejunum and mesenteric lymph nodes.
    Yang Q; Zhang T; Fang N; Sun W
    Pathol Int; 2024 Jun; 74(6):356-358. PubMed ID: 38656535
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anaplastic lymphoma kinase positive anaplastic large cell lymphoma with cardiac infiltration: a case report].
    Yuan FF; Yin QS; Mi RH; Chen L; Xiong YY; Wei XD; Song YP
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):351-352. PubMed ID: 32375454
    [No Abstract]   [Full Text] [Related]  

  • 18. FDG PET/CT in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma.
    Angamuthu M; Kaur K; Tripathi M; Meena JP; Seth R; Kumar R
    Clin Nucl Med; 2020 Jul; 45(7):540-541. PubMed ID: 32404708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
    Petrelli F; Lazzari C; Ardito R; Borgonovo K; Bulotta A; Conti B; Cabiddu M; Capitanio JF; Brighenti M; Ghilardi M; Gianni L; Barni S; Gregorc V
    PLoS One; 2018; 13(7):e0201425. PubMed ID: 30052658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous anaplastic large cell lymphoma.
    Daar G; Küpeli S; Yalçin B; Kesik V; Orhan D; Büyükpamukçu M
    Pediatr Hematol Oncol; 2010 Oct; 27(7):558-63. PubMed ID: 20624005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.